Connect with us

Hi, what are you looking for?


FDA Grants Emergency Use Authorization For COVID-19 Vaccine

U.S. allows emergency COVID-19 vaccine to try and end pandemic.

The US Food and Drug Administration has approved the Pfizer and BioNTech coronavirus vaccine for emergency use in the United States, it was announced late Friday night.

The FDA announced the approval came following a recommendation from its Vaccines and Related Biological Products Advisory Committee. The FDA’s approval will now begin a rapid process for the federal government’s distribution of the vaccine to 64 states,  territories and major cities across the country.

President Donald Trump tweeted out a video, calling the news “medical miracle”.

The government is currently planning to distribute 2.9 million doses of the vaccine within 24 hours and will follow that up with 2.9 million doses 21 days later for those patients to receive their second shot.

The news of the vaccine getting emergency approval comes as the coronavirus pandemic surging across the country at a higher rate than ever before. Hospitals across the nation are seeing more infected patents now than ever before and the outbreak is expected to set even more grim records.

The director of the Centers for Disease Control and Prevention, Dr. Robert Redfield had a grim warning for the country earlier this week, saying next few months of the pandemic would be “the most difficult in the public health history of this nation.”

Advertisement. Scroll to continue reading.

The U.S. joins the U.K. and several other countries to try and vaccinate as many people as possible ahead of what is expected to be a very dark winter for the country with the coronavirus spiking in several states.

A vaccine made by Moderna, Inc. is under consideration by the U.S. that could be ready in a week. Meanwhile, Johnson & Johnson is expecting to learn if its vaccine is working in final testing in January.

Europe is also expected to make its own decision on the Pfizer-BioNTech later this month. Friday Sanofi and GSK announce their early tests showed their vaccine didn’t work well enough in older adults.

Stephen Anderson
Written By

Stephen Michael is a Political Correspondent based in the United States. He has reached a global audience with his coverage of the 2020 Election and Trump White House. Michael joins Forward Axis News after spending time with the Project Spurs Network since 2014 and covering reality TV in the UK, Australia, and Canada.

You May Also Like


The new boosters are expected to be available this week.

White House

President Biden tested negative and will continue to test at regular intervals.

Election 2024

WASHINGTON — Democratic presidential candidate Robert Kennedy Jr. defended his comments where he touted a false Covid-19 conspiracy theory while […]


Dr. Anthony Fauci, President Joe Biden's chief medical adviser, has previously said Covid-19 will be a seasonal occurrence such as the flu or the...